MedTrace Logo

Bioavailability of Astaxanthin Formulations

NCT03443882 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-05-21

No results posted yet for this study

Summary

Bioavailability of dietary supplement formulations in healthy volunteers after a single oral dose.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Astaxanthin

an oral dose form

Sponsors & Collaborators

  • Algatechnologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Rafael Bitzur, MD · Bert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-25
Primary Completion
2019-05-02
Completion
2019-05-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443882 on ClinicalTrials.gov